Renin-angiotensin-aldosterone system inhibitors and adverse outcomes of COVID-19: a Danish nationwide cohort study (ACE-I/ARB and COVID-19)

ENCePP Code of conduct

No

Data sources

• Data source(s):
  Danish registries (access/analysis)
• Data sources (types):
  Administrative healthcare records (e.g., claims)

  Other
• Data sources (types), other:
  The Danish Microbiology Database

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No